BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32071343)

  • 1. MiR-4435 is an UQCRB-related circulating miRNA in human colorectal cancer.
    Hong JW; Kim JM; Kim JE; Cho H; Kim D; Kim W; Oh JW; Kwon HJ
    Sci Rep; 2020 Feb; 10(1):2833. PubMed ID: 32071343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
    Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
    Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A panel of six-circulating miRNA signature in serum and its potential diagnostic value in colorectal cancer.
    Maminezhad H; Ghanadian S; Pakravan K; Razmara E; Rouhollah F; Mossahebi-Mohammadi M; Babashah S
    Life Sci; 2020 Oct; 258():118226. PubMed ID: 32771555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-10a-5p downregulation in mutant UQCRB-expressing cells promotes the cholesterol biosynthesis pathway.
    Kim JE; Hong JW; Lee HS; Kim W; Lim J; Cho YS; Kwon HJ
    Sci Rep; 2018 Aug; 8(1):12407. PubMed ID: 30120311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. microRNA-16-5p-containing exosomes derived from bone marrow-derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2.
    Xu Y; Shen L; Li F; Yang J; Wan X; Ouyang M
    J Cell Physiol; 2019 Nov; 234(11):21380-21394. PubMed ID: 31102273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiRNA-206 suppresses PGE2-induced colorectal cancer cell proliferation, migration, and invasion by targetting TM4SF1.
    Park YR; Seo SY; Kim SL; Zhu SM; Chun S; Oh JM; Lee MR; Kim SH; Kim IH; Lee SO; Lee ST; Kim SW
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30135139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircFNDC3B sequestrates miR-937-5p to derepress TIMP3 and inhibit colorectal cancer progression.
    Zeng W; Liu Y; Li WT; Li Y; Zhu JF
    Mol Oncol; 2020 Nov; 14(11):2960-2984. PubMed ID: 32896063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
    Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
    Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial UQCRB as a new molecular prognostic biomarker of human colorectal cancer.
    Kim HC; Chang J; Lee HS; Kwon HJ
    Exp Mol Med; 2017 Nov; 49(11):e391. PubMed ID: 29147009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
    Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
    Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating exosomal microRNAs as biomarkers of colon cancer.
    Ogata-Kawata H; Izumiya M; Kurioka D; Honma Y; Yamada Y; Furuta K; Gunji T; Ohta H; Okamoto H; Sonoda H; Watanabe M; Nakagama H; Yokota J; Kohno T; Tsuchiya N
    PLoS One; 2014; 9(4):e92921. PubMed ID: 24705249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
    Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
    Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
    Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-21 promotes proliferation, migration, and invasion of cervical cancer through targeting TIMP3.
    Zhang Z; Wang J; Wang X; Song W; Shi Y; Zhang L
    Arch Gynecol Obstet; 2018 Feb; 297(2):433-442. PubMed ID: 29177591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA-Sequencing Based microRNA Expression Signature of Colorectal Cancer: The Impact of Oncogenic Targets Regulated by
    Hozaka Y; Kita Y; Yasudome R; Tanaka T; Wada M; Idichi T; Tanabe K; Asai S; Moriya S; Toda H; Mori S; Kurahara H; Ohtsuka T; Seki N
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNA-762 upregulation in colorectal cancer may be accompanied by Wnt-1/β-catenin signaling.
    Lai PS; Chang WM; Chen YY; Lin YF; Liao HF; Chen CY
    Cancer Biomark; 2021; 32(2):111-122. PubMed ID: 34092606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-21 promotes proliferation, migration, and invasion of colorectal cancer, and tumor growth associated with down-regulation of sec23a expression.
    Li C; Zhao L; Chen Y; He T; Chen X; Mao J; Li C; Lyu J; Meng QH
    BMC Cancer; 2016 Aug; 16():605. PubMed ID: 27495250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.